Expertise in
29
conditions

Dr. Christopher R. Mason

Hematology | Oncology
C.R. Wood Cancer Center
102 Park St, 
Glens Falls, NY 
Clinical Trials:Currently Recruiting for 2 Trials
17 Years of Experience
Expertise in
29
conditions
C.R. Wood Cancer Center
102 Park St, 
Glens Falls, NY 

Overview

Christopher Mason is a Hematologist and an Oncologist practicing medicine in Glens Falls, New York. He has been practicing medicine for over 17 years.

Dr. Mason is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Familial Pancreatic Cancer, Paget Disease of the Breast, and Bone Marrow Aspiration.

He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 5 clinical trials.

Graduate Year

2009

Specialties

Hematology
Oncology

Licenses

Internal Medicine in NY

Hospital Affiliations

Elizabethtown Community Hospital
Saratoga Hospital
Albany Medical Center Hospital
Glens Falls Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital District Physicians Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MVP Health
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

C.R. Wood Cancer Center
102 Park St, Glens Falls, NY 12801

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase 3 Trial for Newly Diagnosed Multiple Myeloma Not Intended for Early Autologous Transplantation
Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase 3 Trial for Newly Diagnosed Multiple Myeloma Not Intended for Early Autologous Transplantation
Enrollment Status: Recruiting
Publish Date: August 19, 2026
Intervention Type: Other, Biological, Drug
Study Drugs: Bortezomib, Daratumumab and Hyaluronidase-fihj, Dexamethasone, Lenalidomide
Study Phase: Phase 3
Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
Enrollment Status: Recruiting
Publish Date: August 19, 2026
Intervention Type: Other, Biological, Drug
Study Drugs: Daratumumab, Dexamethasone, Lenalidomide
Study Phase: Phase 3
A Randomized Phase III Study of the Addition of Venetoclax to Ibrutinib and Obinutuzumab Versus Ibrutinib and Obinutuzumab in Untreated Younger Patients With Chronic Lymphocytic Leukemia (CLL)
A Randomized Phase III Study of the Addition of Venetoclax to Ibrutinib and Obinutuzumab Versus Ibrutinib and Obinutuzumab in Untreated Younger Patients With Chronic Lymphocytic Leukemia (CLL)
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Procedure, Drug, Biological
Study Drugs: Ibrutinib, Obinutuzumab, Venetoclax
Study Phase: Phase 3
A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (>/= 65 Years of Age) With Chronic Lymphocytic Leukemia (CLL)
A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (>/= 65 Years of Age) With Chronic Lymphocytic Leukemia (CLL)
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Drug, Biological, Other
Study Drugs: Ibrutinib, Obinutuzumab, Venetoclax
Study Phase: Phase 3
A Phase II/III Randomized Study of R-MiniCHOP With or Without CC-486 (Oral Azacitidine) in Participants Age 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma, Grade IIIB Follicular Lymphoma, Transformed Lymphoma, and High-Grade B-Cell Lymphomas With MYC AND BCL2 and/or BCL6 Rearrangements
A Phase II/III Randomized Study of R-MiniCHOP With or Without CC-486 (Oral Azacitidine) in Participants Age 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma, Grade IIIB Follicular Lymphoma, Transformed Lymphoma, and High-Grade B-Cell Lymphomas With MYC AND BCL2 and/or BCL6 Rearrangements
Enrollment Status: Active_not_recruiting
Publish Date: July 08, 2026
Intervention Type: Drug, Biological, Procedure, Other
Study Drugs: Cyclophosphamide, Doxorubicin Hydrochloride, Oral Azacitidine, Prednisone, Rituximab, Vincristine Sulfate
Study Phase: Phase 2/Phase 3
View 3 Less Clinical Trials

2 Total Publications

Myelodysplastic syndromes spatial clusters in disease etiology and outcome.
Myelodysplastic syndromes spatial clusters in disease etiology and outcome.
Journal: Leukemia & lymphoma
Published: July 11, 2015
Similar Doctors
Expertise in
69
conditions
Dr. Edward M. Liebers
Hematology | Oncology
Expertise in
69
conditions
Dr. Edward M. Liebers
Hematology | Oncology
Referral may be required

C.R. Wood Cancer Center-Oncology And Hematology

3 Care Ln, 
Saratoga Springs, NY 
 (17.3 miles away)
518-226-6000
Languages Spoken:
English
See accepted insurances

Edward Liebers is a Hematologist and an Oncologist practicing medicine in Saratoga Springs, New York. Dr. Liebers is highly rated in 69 conditions, according to our data. His clinical expertise encompasses Gaucher Disease, Gaucher Disease Type 3, Gaucher Disease Type 1, and Gaucher Disease Type 2.

Expertise in
95
conditions
Dr. Allan D. Eisemann
Hematology | Oncology
Expertise in
95
conditions
Dr. Allan D. Eisemann
Hematology | Oncology
Referral may be required

Rutland Hospital Inc.

160 Allen St, 
Rutland, VT 
 (40.1 miles away)
802-747-1831
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Allan Eisemann is a Hematologist and an Oncologist practicing medicine in Rutland, Vermont. Dr. Eisemann is highly rated in 95 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Anemia, Bone Marrow Aspiration, and Endoscopy. Dr. Eisemann is currently accepting new patients.

Expertise in
41
conditions
Dr. John Delmonte
Hematology | Oncology
Expertise in
41
conditions
Dr. John Delmonte
Hematology | Oncology
Referral may be required

C.R. Wood Cancer Center-Oncology And Hematology

3 Care Ln, 
Saratoga Springs, NY 
 (17.3 miles away)
518-226-6000
Languages Spoken:
English
See accepted insurances

John Delmonte is a Hematologist and an Oncologist practicing medicine in Saratoga Springs, New York. Dr. Delmonte is highly rated in 41 conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Adult Immune Thrombocytopenia.

Frequently Asked Questions about Dr. Christopher R. Mason

How do I make an appointment with Dr. Christopher R. Mason?

You can book an appointment with Dr. Christopher R. Mason by calling their office at 518-926-6620. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Christopher R. Mason a top-rated expert for Pleuropulmonary Blastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Christopher R. Mason is classified as an Advanced expert for Pleuropulmonary Blastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Christopher R. Mason specialize in?

While Dr. Christopher R. Mason is a Hematology, they have specific expertise in Pleuropulmonary Blastoma, Lung Cancer, and Familial Pancreatic Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Christopher R. Mason participate in research or clinical trials?

Yes. Dr. Christopher R. Mason has published 2 articles and abstracts on conditions like Pleuropulmonary Blastoma. You can view a list of Dr. Christopher R. Mason's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Christopher R. Mason accept my insurance?

Dr. Christopher R. Mason accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 518-926-6620 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mason's expertise for a condition
ConditionClose
      View All 29 Advanced Conditions
      View All 103 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile